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It has long been recognized that preexisting antibody, either endogenously  formed, 
or passively administered near the time of the injection of the corresponding antigen, 
can affect the subsequent antibody response.  An excess or, in some cases,  even an 
equivalent amount of passively administered antibody can partially or completely 
inhibit the primary response in a previously unchallenged  animal (1-12)  and passively 
administered  or  previously  synthesized  antibody  may,  under  certain  conditions, 
diminish the response to a secondary challenge  (10, 13-15).  On the other hand, with 
certain antigens, relatively small amounts of passively administered antibody actually 
may enhance the antibody response (12, 16-18). 
The mechanism by which preexisting or passively transferred antibody suppresses 
the antibody response is not entirely clear. It could be either by covering the immuno- 
genic  sites of the antigen and thereby preventing or diminishing  the immunogenic 
stimulus, or by a  direct suppressive action on the cells destined  to respond to the 
antigen. In the broad sense, either of these actions might be considered  a  "feedback 
mechanism" since the product of the response,  antibody, would serve, directly or in- 
directly, to prevent or diminish the response. Most of the available observations of this 
phenomenon are based on experiments which  utilize  complex antigens and at least 
equivalent or, more often, large excesses of antibody in relation to the immunogenic 
challenge  and are, therefore, of little help in choosing between these two possibilities 
(8-14).  Those experiments designed  to  eliminate  the  excess antibody by exposing 
potentially immunocompetent cells to passive antibody prior to or during transfer to 
unresponsive hosts have led to conflicting results (10, 11). 
The  present  studies,  in  which  giant  keyhole  limpet  hemocyanin  (KLH) 
was used as an antigen in rabbits, were undertaken in an attempt to learn more 
of  the  mechanism by which  antibody  affects antibody  synthesis.  The KLH 
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rabbit system has advantages for such a  study since the  primary antibody re- 
sponse is slowly mounted and well sustained,  allowing easy manipulation and 
observation  of its various  temporal  stages.  Also  the  interaction  of KLH  and 
anti-KLH  can  be  quantitated  and  characterized  by  immunochemical  pro- 
cedures which afford some insight into the molecular interactions  involved in 
the suppression of the antibody response. The importance of the temporal rela- 
tionship between administration of antigen and antibody in achieving immuno- 
suppression,  the quantitative  relationship  between  the antigenic stimulus and 
the amount of passively administered  antibody needed to effect suppression of 
the antibody response, and some of the qualitative characteristics of immuno- 
suppressive  antibody have been explored.  The observations reported  strongly 
suggest that the inhibitory effect of antibody is via neutralization  of the anti- 
genic stimulus. Further, they indicate that this neutralization takes place at the 
level of individual  antigenic determinants,  not entire  antigenic molecules,  and 
that the neutralized  material probably exists within or fixed at the surface of 
cells.  Since  early primary antibody has very little  immunosuppressive  effect, 
it seems questionable  whether antibody formed in the primary response is an 
important  regulator  of the  process of antibody  synthesis.  Finally,  it  appears 
that a  very small part of the intravenously administered  KLH  ever  becomes 
immunogenic,  i.e.,  effective  in  stimulating  antibody  formation.  In  this 
paper the term irnmunogen will be used to indicate those antigen molecules or 
antigen  fragments  that  actually  stimulate  antibody  synthesis,  in  contrast  to 
the term antigen which indicates all foreign, potentially immunogenic material 
administered  to a subject. 
Materials and Methods 
Albino male rabbits weighing 5-6 lb. were used as experimental subjects. Associated KLH 
(mol wt 7.5  X  10  ~) purified by ultracentrifugation  (19) was used as antigen  in all experi- 
ments. Incomplete Freund  adjuvant containing KLH used in some immunizations was pre- 
pared by mixing in a Waring Blendor 9 parts of Bayol F, 1 part Arlacel C and 10 parts of 
0.15 M saline containing the KLH. In some experiments the KLH or purified anti-KLH in- 
corporated in these adjuvants was labeled with  ~31I (20) and its rates of loss from the injec- 
tion depot  and/or whole body were determined  as previously described  (21). 
Anti-KLH determinations  were made with  a modified quantitative  precipitin  technique 
using dissociated KLH (mol wt 814,000) as previously described (21). These results are ex- 
pressed as micrograms of dissociated KLH nitrogen precipitated  by 1 ml of antiserum  at 
the point where 80% of the KLH added is precipitated  (p80 units).  Under these conditions 
the  anti-KLH-K.LH ratio  is  slightly  greater  than  two  (19). Direct  determination  of the 
amount  of antibody  per ps0 unit  by  precipitation  of  labeled antibody from  131I-labeled 
3,-globulin preparations  of known pS0 from several hyperimmune antisera in the presence of 
excess KLH gave an average value of 11.0/zg antibody protein/P s° unit. 
In most  studies,  the antibody that was passively administered  was from  two pools of 
hyperimmune  sera from rabbits  repeatedly immunized by a variety of routes over a period 
of 3 or more months. These pools had antibody concentrations  of 900 and 300 p80 units/ml DIXON~ JACOT-GUILLAP.MOD~  AND  McCONAHEY  1121 
respectively. Antibodies from these two pools as measured by the p80 technique were equally 
immunosuppressive. In particular procedures, early primary rabbit anfi-KLH, mink or rat 
hyperimmune anti-K.LH, the 7S ~,-globulin  from the primary or hyperimmune rabbit anti- 
KLH, and slow and fast 7S antibodies from hyperimmune rabbit anfi-KLH or hyperimmune 
TABLE I 
The Rdationship  of Time of Administration  and Suppressive Effect of Intravenously 
Transferred Antibody 
Passive antibody 
pso u~dts 
0 
45 
45 
45 
45 
90 
90 
90 
1800 
1800 
Time of administration 
No. of rabbits  pre (-) or post (+) 
antigen 
2 mg KLI~[ i,v. 
-- 1 day 
+lhr 
+1 day 
+4 day 
--  1 day 
+lhr 
+1 day 
+4 day 
+IM 
+4d~ 
+8d~ 
+6d~* 
+8d~ 
63 
4 
3 
37 
5 
10 rng KT.]~  LV. 
I n° uni~ 
0  6 
18  4  -- 1 day 
18  4  +1 day 
100 rag KLH t.v. 
Average antibody response 
pso  units 
0 
90 
9O 
--1 day 
+1 day 
Day 20  [  Day 30 
I  pso  ands  pu units 
9.2  5.9 
2.5  2.4 
6.5  5.8 
0.9  1.6 
2.0  2.1 
0.3  0.3 
0.8  1.7 
0.1 
2.6 
0.3  0.2 
0.9  1.4 
5.0  4.2 
1.4  1.7 
2.2  2.0 
9.0  6.3 
9.2 
2.4  3.3 
11.5  8.l 
20.7 
12.7  12.3 
* Rabbits' own ps0 1.1 before passive antibody. 
Rabbits' own pso 1.3 before passive antibody. 1122  EFFECT  OF  ANTIBODY  ON  ANTIBODY  SYNTHESIS 
rabbit  anti-abalone hemocyanin  (AH)  which  cross-reacts  with  KLH  were  passively  ad- 
ministered. These preparations are described in more detail in connection with the experi- 
ments in which they were used. 
EXPERIMENTAL  DESIGN 
(a) The first experiments were designed to determine the inhibitory effect on the primary 
antibody response of hyperimmune rabbit antibody passively administered intravenously to 
rabbits at different times in relation to the intravenous injection of antigen (Table I). With an 
TABLE  II 
The Rdakionship baween Size of Intravenous Antigenic Stimulus and Amount of 
Intravenously Transferred Immunosuppressive Antibody Given 1 Day Later 
KIM 
mg 
0.2 
0.6 
0.6 
10 
10 
10 
100 
100 
Passive antibody 
pso 
0 
1 
4 
9 
18 
45 
0 
27 
45 
0 
90 
units 
0 
No. of rabbits 
11 
10 
Antibody response 
.~o units 
63 
5 
11 
37 
4 
4 
Day 20  Day 30 
pSO units 
3.6  4.0 
9.9  6.6 
1.8  2.2 
9.2  5.9 
10.1  6.5 
5.0  4.9 
0.9  1.6 
0.4  0.8 
0.1 
9.0  6.3 
4.1  5.3 
1.4  3.0 
11.5  8.1 
12.7  12.3 
intravenous challenge of  2  mg  KLH,  four  doses of passively administered antibody were 
employed (1800,  90, 45, and 9 pS0 units) and they were administered 1 day before and 1 hr, 
1 day, 4  days, 6 days, and 8 days after the antigen. With 10 mg KLH,  18 pS0 units were 
given 1 day before and 1 day after antigen, and with 100 mg KLH, 90 pSO units were given 
1 day before and 1 day after antigen. Antibody levels were determined 20 and 30 days after 
antigen injection,  the  time of  maximum  serum  antibody  response  (21). 
(b)  The second  series of  observations dealt with the quantitative relationship between 
the intravenous antigenic stimulus and the passively administered immunosuppressive anti- 
body. A series of intravenous antigenic stimali (0.6,  2, 10, and 100 mg KLH) was inhibited 
by a  variety of  doses  of  hyperimmune anti-KLH  given intravenously 1  day  after injec- 
tion of KLH as shown in Table II. Again, serum antibody levels of the recipients were deter- 
mined 20 and 30 days after injection of antigen. DIXON~ JACOT-GUILLARMOD~ AND  MCCONAHEY  1123 
(c) The third series of experiments was intended to reveal some of the characteristics of 
the passively administered  antisera which were related to their immunosuppressive action. 
The possible role of nonantibody  factors in causing inhibition was checked by attempting 
inhibition with unrelated hyperimmune antisera.  Five rabbits were given 2 nag KLH intra- 
TABLE HI 
E~ea of Early and Late Intravenously Transferred Antibody on Primary Respons~ 
to 2 mg KLH 
Antibody administered  1 day after KLH. 
% of day 20 
Type of passive  antibody  Passive  No. of  control 
antibody  rabbits  response 
p  so unils 
7 Day adjuvant primary pool  20  4  70 
"  "  150  4  84 
"  "  7S7G*  100  4  73 
9 Day  "  "  100  10  60 
20 Day normal primary pool 
20 Day X-ray primary pool 
21 Day adjuvant primary ($2-47) 
20  4  57 
20  5  67 
20  5  62 
48 Day X-ray primary pool 
50 Day adjuvant primary (~2-47) 
20  4  28 
20  4  25 
90 Day adjuvant primary (~:2-47)  20  4  13 
....  (t2-46)  20  4  t9 
....  (,2..45)  20  4  32 
7 Day normal secondary ($~89)§  20  5  8 
21 Day  ....  (~4~89)  §  20  4  5 
21 Day  ....  (~:4-91)  §  20  4  16 
Hyperimmune pool  9  9  18 
Hyperimmune pool plus  9  6  14 
9 Day primary antibody  100 
* 7S~/-giobulin obtained by chromatography on DEAE (23). 
I; Individual rabbit numbers. 
§ Second injection of KLH 95 days after first injection. 
venously followed by 600  pS0 units of rabbit anti-bovine serum albumin 1 day later. Also, 
any effect of nonantibody factors in the immunosuppressive  anti-KLH sera  was looked for 
by attempting to inhibit the response of rabbits given 2 nag KLH intravenously with serum 
injected 1 day later which originally contained 900 anti-KLH pS0 units but had been absorbed 
at equivalence with KLH before injection. 
Next, the relative inhibitory power of rabbit anti-KLH formed at different times after 
initial immunization was determined  (Table HI). In order to obtain sufficient amounts  of 
donor primary antibody,  either KLH was given in incomplete adjuvant  (21)  (3 mg KLH 
in 2 ml adjuvant/rabbit)  or the primary response to 2  mg intravenously was enhanced by 1124  EFFECT  OF  ANTIBODY  ON  ANTIBODY  SYNTHESIS 
X-my  (22)  (500  r  given 2 hr  after  intravenous  KLH). These  procedures  increasod  and 
accelerated the primary antibody responses.  Antibody obtained from rabbits 7 and 21 days 
after the second of two injections of 2 mg KLH given intravenously 95 days apart was also 
tested for inhibitory action. 
The inhibitory power of anti-KLH obtained from mink and  rats  repeatedly irnrnu~ 
over a period of more than 3 months was tested in rabbits given 2 mg KLIt intravenously. 
The mink antiserum  contained  230  p80 units/ml and  the rat  antiserum  200 ps0 units/ml. 
Because the half-lives of rat and mink 7-globulins in rabbits were 1.7 and 1.3 days, respectively, 
in contrast to approximately 6 days for rabbit 7-globulin, these heterologous anthem were 
given repeatedly to two groups of rabbits,  1 hr (60 pS0 units), 2 days (50 ps0 units), and 5 
days (50 pS0 units)  after the injection of KLH in order to maintain their level in the circu- 
12. 
11: 
10- 
•  ,c  5' 
4. 
3. 
2- 
~Control, No Passive  Ab. 
4.5 P80  Oay 0 
9 P80  Day O 
18 PBO  Oay 0 
10  20  30  50  70  100 
Days Following KLH Injection 
Fro. 1. The immunosuppressive effect of intravenously administered p~ve  anti-KLH on 
the response  to 2 #g KLH in adjuvant. 
lation. One group of five rabbits received a single injection of 20 pS0 units of rat anti-KLH 
1 day after 2 mg KLH, and one group of four rabbits received two injections of 50 pS0 units 
of mink anti-KLH 1 hr and 2 days after 2 mg KLH. 
The  immunosuppressive  quality  of  an  antibody  cross-reactive with  KLIt  was  tested. 
Sera from rabbits  hyperimmunized with AH cross-reacted approximately 50% with KLH, 
i.e., such antisera when tested with KLH had pS0 values of approximately one-half that when 
tested  with AH. Conversely, hyperimmune  anti-KLH precipitated  approximately 20O/o as 
much AH as KLH and from 20-40°/0  of the anti-KLH antibodies from such sera could be 
absorbed  out with an excess of AH. Three groups of five rabbits were given 2 mg KLH in- 
travenously and 1 day later each received one of three doses of rabbit hyperimmune anti-AH 
serum. These doses of anti-AH were measured in terms of antibody cross-reacting with KLH, 
i.e., by the precipitation of KLH, and were 9, 20, and 100 p80 units. The anti-KLtt response 
was determined 20 and 30 days after the injection of KLH. 60 days after the initial injection 
of KLH, these rabbits received a  second injection of 2 mg of KLH and the cross-re~ctivlty DIXON~ ~ACOT-GUILLAP.MOD~ AND  McCONAHE¥  1125 
of the antibody formed in the secondary response was tested against AH in the pS0 procedure 
and compared with the antibody made in rabbits comparably stimulated but without receiv- 
ing anti-AH. 
The immunosuppression produced by slow and fast 7S hyperimmune anti-KLH antibodies 
as  separated  by  DEAE  chromatography  was  observed.  Ammonium  sulfate  precipitated 
~/-giobulin  from the antisera were fractionated by DEAE chromatography according to the 
14- 
13. 
12. 
11- 
10- 
9- 
8- 
~  6- 
.-.-~[ontv~l, Ha Passive  Ab. 
o----o 0.]  P80 
,,.  ~.0. a, P8Q 
,,.---.o  1 P8Q  ~'~ 
,,-~,  3 P80 
10  20  30  50  70  100 
Days Following Injection 
Fzo. 2. The immunosuppressive effect of various amounts of anti-KLH incorporated with 
2/~g KLH in adjuvant. 
method of Sober et al. (23). One group of five rabbits received 9 pS0 units of slow 7S antibody 
1 day after 2 nag KLH and another group of five received 9 ps0  units of fast 7S antibody. 
The responses were measured 20 and 30 days after injection of KLH. 
(d)  The fourth  set  of experiments  involved the immunization of rabbits  with KLH in 
incomplete Freund adjuvant and the inhibition of the antibody response with intravenously 
administered  hyperimmune  rabbit  anti-KLH.  As previously reported,  2  #g KLH in 2  ml 
adjuvant elicits an antibody response slightly greater and better sustained than that induced 
by 0.6-2 rag KLH given intravenously (21).  Five groups of rabbits  received 2 #g KLH in 
a total of 2 ml adjuvant in the four footpads and multiple subcutaneous sites. Simultaneously, 
three of these groups consisting of 11,  13,  and  12  rabbits  received, respectively, 4.5,  9, or 
18 pS0 units of anti-KLH intravenously. One group of five rabbits  received 18 pS0 units 7 
days after antigen administration and the final group of 39 rabbits served as an antigen only 
control. Antibody levels in all rabbits were determined 14, 20, 30, 50, 70, and 100 days after 
antigen injection and are presented in Fig. 1. The rate of elimination of 2/zg of mI KLH in 1126  EFFECT OF ANTIBODY ON  ANTIBODY SYNTHESIS 
adjuvant from the adjuvant depot and/or whole body was observed in eight rabbits in the 
absence of passive antibody. 
(e) The final experiment was designed to compare the immunosuppressive efficiency of 
passive antibody distributed throughout the host versus antibody concentrated in the vicinity 
of the antigen.  It also allowed us to determine  the precise amount of antibody needed to 
neutralize  the immunogenicity of a  known amount of KLH. i.e., the minimum antibody- 
antigen ratio of a nonimmunogenic mixture. Various amounts of anti-KLH were mixed with 
KLH and incubated at 37°C for 30 rain and at 4°C for 2 days before being incorporated into 
incomplete adjuvant for injection. 7 rabbits  received 2 #g KLH plus 0.1 pSO, 1.1  /zg anti- 
KLH in adjuvant; 10 received 2 #g KLH plus 0.4 pS0, 4.4/zg anti-KLH; 8 received  2 #g 
KLH plus  1 p80, 11 /zg anti-KLH; 8 received 2 /~g KLH plus  3 ps0, 33 /~g anti-KLH; 
and 11 received 2/zg KLH plus 9 pS0, 99 ~ug anti-KLH. Levels of anti-KLH in the sera  of 
these recipients were determined  14, 20, 30, 50, 70, and 100 days later and are presented in 
Fig. 2. The rate of loss of antibody from the adjuvant and the whole animal was determined 
using 131I-labeled 7S "~-globulin from hyperimmune  anti-KLH sera  which was 60% precip- 
itable with KLH. The labeled globulin was incorporated into adjuvant alone or with KLH 
at a ratio of 50:1 and its rate of loss from injection site and whole body determined. 
KESULTS 
The  results  of the  studies  in  which  immunosuppressive  doses  of antibody 
were intravenously administered  at various  times relative  to the injection  of 
antigen are given in Table I. Clearly, 9 psc units of antibody are most effective 
in suppressing the response to 2 mg KLH intravenously if given 1 day after KLH. 
The same amount of anti-KLH given 1 day before,  1 hr after or 4  days after 
KLH was less effective. 45 ps0 units of anti-KLH was effective in suppressing 
the  response  to  2  mg if given  1 day before or  1 hr after  KLH  but was less 
effective if given 4 days after. 90 ps0 units was an effective immunosuppressant 
if given either 1 hr or 4 days after KLH but was less than 50 %  suppressive if 
given 8 days after.  1800 ps0 units given 6 or 8 days after K.LH when the re- 
cipients  already  had  anti-KLH  levels of their  own of 1.1  and  1.3  ps0  units, 
respectively, resulted in an apparent 70-80% suppression of antibody response. 
Actually with  1800 ps0 units,  a  significant part of the  antibody measured on 
day 20, and to a lesser extent on day 30, was probably passively administered 
antibody so that suppression of antibody synthesis may have been greater than 
the antibody levels indicate.  With a  challenge of 10 mg of KLH,  18 pa0 units 
given 1 day before KLH caused no suppression while the same amount given 1 
day after KLH  reduced  the  20 day response  to one-fourth the control level. 
With 100 mg KLH, 90 ps0 units given 1 day after KLH produced no immuno- 
suppression and if given 1 day before, KLH may have actually enhanced the 
antibody response. 
The quantitative  relationships between intravenous challenges of KLH and 
immunosuppressive doses of anti-KLH given 1 day later are shown in Table II. 
First,  it is apparent that challenges of 0.6-100 mg of KLH unaccompanied by 
passively administered antibody give comparable antibody responses 20 and 30 
days  later  while  0.2  mg  elicits  a  significantly  smaller  response.  4  ps0  units DIXONj  JACOT-GUILLARMOD,  AND  McCONAHEY  1127 
causes  an  80%  suppression  of the  20 day response  to 0.6 mg KLH and  an 
approximately 50% suppression  with 2 mg KLH. 9 ps0 units causes  a  90% 
suppression of the 20 day response  to 2 mg KLH while 18 ps0 units causes  a 
95 % inhibition and 45 ps0 units virtually abolishes the 20 day response to 2 mg 
KLH. When the KLH ch~lenge is raised 5 times,  to 10 mg, approximately 5 
times larger amounts of anti-KLH are needed to give the same degree of im- 
munosuppression seen with 2 mg KLH. 27 ps0 units of anti-KLH given with 10 
mg KLH gives  a  slightly greater degree of immunosuppression than 4.0 ps0 
units gives with 2 mg KLH, and 45 ps0 units inhibits the 20 day response to 10 
mg to nearly the same degree as 9 ps0 units inhibits the response to 2 mg. After 
100 mg KLH, 90 ps0 units had no immunosuppressive effect and much larger 
amounts of antibody could not be  used because  they induced anaphylactic 
reactions. 
In the studies dealing with the nature of the inhibitory antibodies, the results 
were as follows: 
Neither hyperimmune anti-bovine serum albumin serum,  nor hyperimmune 
anti-KLH serum previously absorbed with an equivalent amount of KLH had 
any immunosuppressive effect in the amounts used. 
The inhibitory properties of  anti-KLH  antibodies  obtained  at  different 
times after immunization of the donor are shown in Table III. Antisera taken 
7 and 9 days after adjuvant or X-ray enhanced primary KLH immunization 
are, at best, weakly immunosuppressive, even in large doses. This is true for 
both the entire serum or the 7S 7-globulin fraction thereof. Early antibody will 
not, however, interfere with the immunosuppressive action of hyperimmune 
antibodies as indicated by the full suppression  demonstrated by 9 ps0 units of 
hyperimmune anti-KLH in the presence of 100 units of 9 day primary antibody. 
Anti-KLH antibodies obtained at the 20th or 21st day of normal or enhanced 
primary  responses  were  mildly immunosuppressive;  20  ps0  units  produced 
about a 40 % inhibition. 20 ps0 units of primary antisera obtained 48-50 days 
after immunization produced about a  75 % inhibition of the day 20 response. 
90 day primary antisera in doses  of 20 pso units caused an average of 80% 
suppression.  If such  comparisons are  valid,  the  90  day primary antibodies 
would appear to be less than one-half as immunosuppressive as hyperimmune 
antibodies. For donor rabbit 2-47, bled 21, 50, and 90 days after primary im- 
munization,  the immunosuppressive properties of its antibodies appeared to 
increase with time. The immunosuppressive properties of antibodies obtained 
7 and 21 days after a secondary challenge appeared to approach those of hyper- 
immune antibodies. 
Mink and rat hyperimmune anti-KT.H had a moderate immunosuppressive 
effect in rabbits. Those rabbits  receiving 50 ps0 units of mink anti-KLH 1 hr 
and 2 days after 2 mg KLH had average 20- and 30-day responses  of 3.8 ps0 
and 3.6 ps0 respectively and those receiving three injections of mink anti-KLH 1128  EFFECT  OF  ANTIBODY  ON  ANTIBODY  SYNTHESIS 
totaling 160  ps0 units  had average 20- and 30-day responses of 2.1  ps0. The 
rabbits  receiving one injection of 20  ps0 units  of rat anti-KLH given 1 day 
after KLH had 20- and 30-day ps0 values of 4.7 and those receiving three in- 
jections of rat anti-KLH totaling 160 ps0 had 20- and 30-day responses of 1.9 
ps0 units.  Comparison of the immunosuppressive effects of these antisera with 
rabbit antisera is difficult because of their more rapid rate of catabolism; it is 
clear, however, that they are less suppressive. 
Hyperimmune  anti-AH,  which  cross-reacts  with  KLH,  was  partially  im- 
munosuppressive. 9 ps0 units of anti-AH given 1 day after 2 mg KLH resulted 
in an average 20 day response of 4.9 ps0 units, whereas 20 ps0 units given simi- 
larly resulted in average 20-day responses of 2.6 ps0, and 100 pso units an aver- 
age 20 day response of 2.5. At the 9 ps0 dose, anti-AH appeared about 50 % as 
effective in  suppressing  the  anti-KLH response as  hyperimmune anti-KLH. 
However, even at a dose of 100 ps0 units, the anti-AH was not as strongly im- 
munosuppressive as 9 ps0 units of anti-KLH. The secondary anti-KLH made 
in  the  rabbits  with  primary  anti-KLH  responses  partially  suppressed  with 
anti-AH did not cross-react with AH differently than control secondary anti- 
KLH sera. 
Hyperimmune anti-KLH from slow and fast  7S  ~-globulin fractions both 
inhibited similarly and in a manner identical to the same amount of anti-KLH 
of whole serum. 
The response of rabbits to 2/~g KLH in incomplete Freund adjuvant was 
suppressed  by intravenously administered  hyperimmune  anti-KLH  as  indi- 
cated in Fig. 1.4.5 ps0 units given at the time of injection of antigen caused a 
delay and an  approximate  20 %  suppression  of the  antibody response  while 
9 ps0 units similarly administered caused an 75 % inhibition and 18 ps0 units 
slightly less. The injection of 18 ps0 units 7 days after antigen also resulted in a 
60-70%  inhibition.  With  the  adjuvants  prepared in  these  experiments, 131I- 
labeled KLH escaped from the depot site and/or the whole rabbit with a half- 
life of about 17 days during the first 2 postinjection weeks and thereafter with a 
half-life of about 50 days. 
The immunosuppressive effect of anfi-KLH incorporated directly with 2 #g 
KLH in incomplete adjuvant was  considerably greater than when  the  anti- 
KLH was given intravenously (Fig. 2). 0.1-0.4 pa0 units, or 1.1-4.4 #g, of anti- 
KLH caused about  a  one-third suppression  of the  20  and  30  day antibody 
levels which were followed by increasing antibody levels to  control levels or 
greater at 70-100 days.  1 ps0, or 11.0 #g anti-KLH,  which presumably satu- 
rated the KLH, caused an 80%  suppression of 20-30-day levels after which 
antibody levels reached 50%  of control maximum by 50  days.  3  and  9  ps0 
units, 33 and 99 #g  anti-KLH caused only a slightly greater suppression than 
1 pso unit throughout the 100 day observation period. Using 131I-labeled puri- 
fied hyperimmune anti-KLH,  it  was  determined  that,  in  extreme antibody DIXON, ~ACOT-GUILLARK~OD, AND MCCONAHEY  1129 
excess, associated KLH could combine with,  and was saturated by, approxi- 
mately 4 times its weight of antibody. A late increase in antibody response after 
injection of antigen-antibody complexes in adjuvant has been observed previ- 
ously and attributed to dissociation of the complexes with stimulation by free 
antigen  (8). 
mI-labeled  anti-KLH  incorporated  in  these  adjuvants  escaped  from  the 
adjuvant depots and disappeared from the whole body of rabbits at a rate with 
a half-life of 17 days during the first 2 postinjection weeks and thereafter at a 
half-life of somewhat greater than 30 days. 
DISCUSSION 
The temporal and quantitative aspects of the hnmunosuppressive effects of 
passive antibody,  together  with  the  previously observed behavior  of  intra- 
venously administered KLH in rabbits (21), give some indications of the mecha- 
nism of action of the passive antibody. After intravenous administration, KLH 
is cleared from the circulation rapidly so that within 1 hr <  10 % is circulating 
and within 6 hr, only 1.5 % (21). Clearance of antigenic material from the entire 
body is impossible  to quantitate but based on studies employing mI-labeled 
KLH, it appears that after 1 day somewhat  <  10% of the intact KLH may 
persist, after 2 days <7%, and after 3 days <3%. Thus,  the rabbit appears 
capable of rapidly disposing of the greater part of this antigen by nonhnmuno- 
logic means. If the rabbit is allowed 1 day after primary injection to eliminate 
most of the KLH, then the injection of relatively small amounts of anti-KLH 
will inhibit the antibody response.  At this time, injection of only 5-10 % of the 
anti-KLH which would react at equivalence with the injected antigen is strongly 
immunosuppressive. Anti-KLH administered 1 day before and, more particu- 
larly, 1 hr after antigen must encounter most of the injected KLH in the circu- 
lation before the host eliminates it and,  therefore, does not suppress the im- 
mune response efficiently,  although very large amounts of antibody ~ven at 
these times are suppressive.  Of the 9 ps0 units of anti-KLH given 1 day before 
2 mg KLH, only that portion which has equilibrated into  the extravascular 
fluids (about 50%) can escape immediate intravascular reaction with the total 
dose of the injected KLH and it is probably this anti-KLH in the extravascular 
fluids wMch later accounts for the observed partial immunosuppression. 
That  passively administered antibody can interfere with an anti-KLH re- 
sponse already underway is evident by the suppressive effect of as little as 9 ps0 
units given 4 days after 2 mg KLH and of 1800 ps0 units given 6 and 8 days 
after 2 mg KLH (Table I). The rabbits injected at 6 and 8 days already had 
made detectable circulating  anti-KLH prior  to the administration  of passive 
anti-KI.H. Even with KLH administered in adjuvant, passive antibody given 
1 wk later exerted a strong suppressive effect. In these instances it would seem 
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in or on responding cells or perhaps in the process of transfer between cells. 
These results are in agreement with earlier reports of others who used different 
host-antigen systems (8,  10,  12,  15). 
Actually there is no evidence that the presence of anti-KLH prior to the ad- 
ministration of KI.I-I has any immunosuppressive effect such as would be ex- 
pected if the antibody had a  direct effect on potentially responsive cells.  If 
passive antibody directly affected responsive cells, then 9 p~0 units, which was 
an effective immunosuppressant 1 day after 2 mg KLH, would presumably be 
capable of suppressing most of the potentially responsive cells in a rabbit since 
2 mg KLH stimulates a near maximum primary response. However, twice this 
amount of anti-KLH, 18P 8° units, given 1 day before 10 mg KLH, or 90 ps0 
units given 1 day before 100 mg KI.H had no immunosuppressive effect and 
the latter may even have enhanced the response. Thus, no direct adverse effect 
of passively administered antibody on potentially responsive cells was observed. 
The close parallelism between the size  of the antigenic challenge and the 
amount of passive antibody needed to  suppress  the subsequent immune re- 
sponse strongly suggests that the passive antibody acts by neutralizing retained 
antigen. Thus, 4 ps0 units will suppress the response to 0.6 mg KLH to nearly 
the same degree that 9 ps0 units suppresses the response to 2 mg and 45  ps0 
units the response to 10 rag. Similarly, 4.0 ps0 units suppresses the response to 
2 mg KLH to nearly the same extent as 27 p80 units does the response to 10 mg 
KLH. Also,  at  each dose level of antigen, the immunosuppression achieved 
appears  proportional  to  the amount of passive  antibody given. In terms of 
absolute amounts, however, the quantity of passive antibody is far less  than 
could react with the total dose of antigen and is probably reacting with the 
traces of residual antigen not previously eliminated by the host's nonimmune 
mechanisms. 
If one can relate the size of the antibody response to the amount of active 
immunogenic material present in  the  animal, i.e.,  that antigen actually in- 
volved in stimulating antibody formation, it seems that a relatively constant 
amount of immunogen results from challenges with amounts of KLH ranging 
from 0.6 mg to 100 mg [also 1000 mg (21)] since the associated maximum anti- 
body levels are quite similar. However, since larger amounts of passive antibody 
are needed to suppress responses to the larger doses of antigen, it would appear 
that amounts of nonimmunogenic antigen proportional to  the  total antigen 
given may be retained in a form capable of combining with the passively ad- 
ministered antibody. Such nonimmunogenic antigen might be inactive because 
of its  anatomical position,  or its immunochemical form or it might merely 
represent an excess of potential immunogen to which the host is incapable of 
responding. 
That the  passive  antibody acts  by neutralizing  antigen  rather  than directly 
on  immunocompetent ceils  is  further  suggested  by the experiments  using  KLH DIXON,  JACOT-GUILLARMOD, AND  MCCONAHEY  1131 
in adjuvant. Antibody incorporated directly with the KLH in the adjuvant was 
about 10 times as effective in immunosuppression over the first 30 days of the 
response as was antibody given intravenously (Figs. 1 and 2). While the shapes 
of the suppressed antibody response curves are not comparable, the 20 and 30 
day levels in rabbits receiving  4.5 1)80 units intravenously and 0.4 I  )80 units in 
adjuvant are similar  as are those of rabbits receiving 9 1)80 units intravenously 
and  1 1)80 in adjuvant. 
The immunosuppressive effect of passively administered heterologous anti- 
bodies further  suggests that  antibody acts by neutralizing  antigen.  A  non- 
antigen  receptor  on  potentially  responsive  cells  for  heterologous  antibodies 
would seem unlikely. That the heterologous antibodies were less effective than 
homologous antibodies in  this  situation might  be expected for at least two 
reasons.  First, the heterologous ~-globulins have much shorter half-llves in the 
rabbit than do homologous. However, when repeated injections of heterologous 
anti-KLH were used, an 80 % suppression was achieved. Second, species other 
than  the rabbit may make less avid antibody to KLH and may respond to 
different antigenic determinants on the K.LH molecules than do rabbits and, 
thus,  provide less effective suppressive  antibody for rabbits than do homol- 
ogous  antibodies.  The  difference  between  these  observations  and  those  of 
Uhr and Baumann  (8) in which heterologous antibodies were more immuno- 
suppressive than homologous may be related to the routes of administration 
used. Administration of heterologous antibody in adjuvant (8) would minimize 
the  effect of any difference  in  circulating  half-life  between homologous and 
heterologous antibodies. 
It is of interest that when minimal doses of intravenous antigen or antigen 
in adjuvant were employed to give roughly comparable antibody responses, 
both responses were suppressable by similar  amounts of intravenous passive 
antibody in spite of the fact that widely different amounts of antigen had been 
injected.  If passively administered  antibody exerts its suppressive effect by 
neutralizing immunogen, it would follow that 2 pg KLH in adjuvant and 2 mg 
intravenously provide comparable amountsof immunogen.  In thiscase, < 1/1000 
of the intravenously administered KLH would become immunogenic. 
Two sets of observations suggest that passive antibody blocks the immuno- 
genic stimulus of KLH at the level of individual antigenic determinants and 
not at the level of the entire antigenic molecule.  The first of these was the fail- 
ure of rather large amounts of cross-reacting anti-AH to suppress completely 
the anti-KLH response.  As  the  experiments  were designed,  the amounts of 
anti-AH used, and which were only partially immunosuppressive, were capable 
of reacting with many more KLH molecules than the complete, or nearly com- 
plete,  immunosuppressive  doses of  anti-K.LH.  However,  there  undoubtedly 
were many KLH specific determinants to which the anti-AH sera contained no 
antibodies and which were,  therefore,  not blocked. The second observations 1132  EFFECT OF ANTIBODY ON ANTIBODY SYNTHESIS 
came from the experiments employing anti-KLH and KLH together in adju- 
vant. Effective immunosuppression was achieved only when saturating amounts 
of anti-KLH were incorporated with the KLH. Equivalent amounts of anti- 
KLH sufficient to precipitate all the KLH but not cover all antigenic deter- 
minants were only slightly immunosuppressive. Thus, it seems likely that in 
immunosuppression the K_LH  molecule as a whole is not neutralized by passive 
antibody but that individual determinants may be blocked. These observations 
differ from those of Uhr and Banmann (8)  which showed that three antitoxin 
molecules could effectively neutralize the immunogenicity of one toxin mole- 
cule, an amount of antibody too small to cover all of the antigenic determinants 
of the toxin molecule. 
Finally, the present data raise questions concerning the role of antibody as a 
regulator of antibody synthesis in  the  course  of normal immune responses. 
Unfortunately, KLH may be a poor antigen for studies on the normal mecha- 
nisms of termination of the antibody response since the primary response to 
this antigen is well sustained. However, it is clear that antibodies, even 7S~,G 
antibodies, formed in the first weeks of the primary response have very little 
immunosuppressive  power  in  contrast  to  antibodies  formed  after  repeated 
immunizations. It is possible that extremely large amounts of early primary 
antibody might  be  suppressive,  but  certainly no  quantitative  comparisons 
between natural events and those seen after passive administration of hyper- 
immune antibody to animals early in a primary response are warranted. It may 
be that at any time during normal responses, the antibody forming cells can 
successfully compete for available immunogen with the antibody normally in 
the circulation at that time. This would fit with the several observations failing 
to demonstrate an immunosuppressive effect of hyperimmune antibody on a 
late or secondary antibody response.  In this situation the antibody forming 
cells may be equal to the task of competing with the passive antibody. 
One possible role of antibody on antibody formation may be to increase with 
time the spectrum of determinants on the antigen to which the host responds. 
Early in an immune response, antibody is made to a limited number of deter- 
minants on the antigen and this number increases with the length of the re- 
sponse,  thereby increasing the heterogeniety of the antiserum and no doubt 
accounting at least in part for its increasing cross-reactivity with other antigens. 
As relatively large amounts of antibody are formed to the most immunogenic 
determinants on an antigen, these sites on the immunogenic material in the 
animal may be partially neutralized and the host then responds to the remain- 
ing uncovered sites of lesser initial immunogenicity. 
Throughout the present experiments, analyses of the various inhibited re- 
sponses for mercaptoethanol sensitive 19S (IVIES) and resistant 7S (MER) anti- 
bodies were made. The relative amounts of these antibodies in normal responses 
have  been  previously  reported  and  the  large  amount  of  MES  antibody DIXON, JACOT-GUILLARMOD,  AND McCONAJKEY  1133 
synthesized  throughout  the  responses  noted  (21).  In  the  partially  inhibited 
responses,  the relative concentrations of MES and MER antibodies were not 
significantly  different from those seen in uninhibited  responses.  This  indicates 
that the inhibition induced by hyperimmune, largely MER, antibody affected 
the synthesis of both MES and MER antibody. These observations fit with 
those reported earlier  (21) indicating that in this system at least, the presence 
of MER antibody does not particularly suppress MES antibody formation. 
SUMMAR~ 
Suppression of the primary response of rabbits to intravenously administered 
KLH can be achieved with very small  amounts of hyperimmune  anti-KLH 
administered a day later since the rabbit apparently rapidly eliminates most of 
the KLH by nonimmunologic means. The amount of passive anfi-KLH needed 
to achieve immunosuppression was directly proportional to the dose of injected 
antigen. 
Antibody passively administered  as much  as 6-8  days after  antigen  still 
can be strongly immunosuppressive, which suggests that the antibody must be 
reacting with immunogen in or on responding cells or perhaps in the process of 
transfer between cells. 
There was no evidence that the presence of passively administered  hyper- 
immune anti-KLH prior to the injection of antigen had any immunosuppressive 
action beyond the direct neutralization of the injected antigen. 
When KLH was injected in Freund adjuvant, anti-KLH incorporated with 
the KLH in the adjuvant was much more efficient in causing immunosuppres- 
sion than  anti-KLH given intravenously. 
The primary responses to 2 mg K_LH given intravenously and 2 #g given in 
adjuvant reached approximately equal peaks and were suppressible by com- 
parable amounts of intravenously administered anfi-K_LH. 
Two observations suggest that passive antibody neutralizes the immunogenic 
stimulus at the level of individual antigenic determinants  and not merely by 
aggregating  or  precipitating  entire  antigenic  molecules.  First,  anti-abalone 
hemocyanin (AH) which cross-reacts approximately 50% with KLH was only 
partially immunosuppressive even in extremely large amounts,  i.e.,  amounts 
which could react with and precipitate much more KLH than could the smaller 
but more suppressive doses of anfi-K_LH. Second,  when KLH and anfi-KLH 
were given together in adjuvant,  effective immtmosuppression  was  achieved 
only with amounts  of anti-KLH  sufficient  to saturate  or cover virtually all 
available antigenic determinants. 
The immunosuppressive quality of passive antibody increases with time after 
immunization and with repeated immunization of the donor.  In view of their 
relatively weak immunosuppressive properties,  antibodies formed in the first 
weeks of a primary response may not contribute significantly  to the turning off 1134  EFFECT  OF  ANTIBODY ON  ANTIBODY SYNTHESIS 
of the antibody response. In any event, results obtained by passive transfer of 
hyperimmune  antibody  to  animals  early  in  a  primary  response  cannot  be 
applied to the natural events in a primary response. 
The authors wish to acknowledge the capable technical assistance of Miss Kaete Lorenz. 
BIBLIOGRAPHY 
1.  Smith, T. 1909. Active immunity produced by so called balanced or neutral mix- 
tures of diphtheria toxin and antitoxin. Y. Exptl. Med. 11: 241. 
2.  Rhoads, C. P. 1931. Immunity following the injection of monkeys with mixtures 
of poliomyelitis virus and convalescent human serum. J. Exptl. Med. 53: 115. 
3.  Kalmanson,  G.  M.,  and  J.  Bronfenbrenner.  1943. Restoration  of  activity  of 
neutralized  biologic agents by removal of the antibody with papain, f. Im- 
munol. 47: 387. 
4.  di Sant' Agnese, P. A. 1949. Combined immunization against diphtheria, tetanus 
and pertussis in new-born infants. II. Duration of antibody levels;  antibody 
titers after booster dose;  effect  of passive immunity to diphtheria on active 
immunization with diphtheria toxoid. Pediatrics. 3: 181. 
5.  Barr, M., A. T. Glenny, and K. J. Randall,  1950. Diphtheria immunization in 
young babies. A study of the factors involved. Lancet. 1: 6. 
6.  Osborn, J. J., J. Dancis, and J. F. Julia. 1952. Studies  of the immunology of the 
newborn infant. II. Interference with active immunization by passive trans- 
placental circulative antibody. Pediatrics. 10: 328. 
7.  Mason, H. H., M. Robinson, and P. A. Christensen.  1955. The active immuniza- 
tion of guinea pigs passively immunized with homologous antitoxin serum. J. 
Hyg. 1i3: 172. 
8.  Uhr, W., and J. Baumann. 1961. Antibody formation. I. The suppression of anti- 
body formation by passively administered antibody. Y. Exptl. Med. 113: 935. 
9.  Neiders, M. E., D. A. Rowley, and F. W. Fitch. 1962. The sustained suppression 
of hemolysin in passively immunized rats. ]. Immunol. 88: 718. 
10.  Rowley, D. A., and F. W. Fitch. 1964. Hemeostasis of antibody formation in the 
adult rat. ]. Exptl. Med. 120: 987. 
11.  Moiler,  G. 1964. Antibody induced  depression  of the immune response:  A study 
of the mechanism in various immunological  systems. Transplantation.  2: 405. 
12.  Moiler,  G.,  and H. Wigzeli.  1965. Antibody synthesis at  the cellular level.  J. 
Exptl. Med. 121: 969. 
13.  Rowley, D. A., and F. W. Fitch. 1965. The mechanism of tolerance produced in 
rats to sheep erythrocytes. I. Plaque-forming cell and  antibody  response  to 
single and multiple injections  of antigen. Y. Exptl. Med. 121: 671. 
14.  Rowley, D. A., and F. W. Fitch. 1965. The mechanism of tolerance produced in 
rats to sheep erythrocytes. II. The plaque-forming cell and antibody response 
to multiple injections of antigen begun at birth. Y. E.xpa. Med. 121: 683. 
15.  Uhr,  J.  W.,  and  J.  B.  Baumann.  1961.  Antibody  formation.  II. The specific 
anamnestic antibody response. J. Exptl. Med. 113: 959. 
16.  Segre, D., and M. L. Kaeberle. 1962. The immunologic  behavior of baby pigs. 
I. Production of antibodies in three week old pigs. ]. Immunol. 89: 782. DIXON,  JACOT-GUILLARMOD~ AND  McCONAHEY  1135 
17.  Terres, G., and R. D. Stoner. 1962. Specificity  of enhanced immunological  sensi- 
tization of mice following injections of antigens and specific antisera. Proc. Soc. 
Exptl. Bio. Med. 109: 88. 
18.  Locke, R. F., D. Segre,  and W. L. Myers. 1964. The immunologic behavior of 
baby pigs. IV. Intestinal absorption and persistence of 6.6S and 18S antibodies 
of ovine origin and their role in the immunologic competence of baby pigs. 
J. Immunol.  93: 576. 
19.  Weigle,  W. O.  1964. Immunochemical properties of hemocyanin. Immunochem- 
istry, l: 295. 
20.  McConahey, P. J., and F. J. Dixon. 1966. A method of trace iodination of proteins 
for immunologic studies. Intern. Arch. Allergy A ppl. Immunol. 29: 185. 
21.  Dixon, F. J., H. Jacot-Guillarmod, and P. J.  McConahey.  1966. The antibody 
responses  of rabbits and rats to hemocyanin. J. Immunol. 97: 350. 
22.  Dixon, F. J., and P. J. McConahey. 1963. Enhancement of antibody formation 
by whole body x-radiation. J. Exptl. Med. 117: 833. 
23.  Sober, H. A., F. J. Gutter, H. M. Wyckoff, and E. A. Peterson. 1958. Chromatog- 
raphy of protein. H. Fractionation of serum protein on anion exchange cellulose. 
J. Am. Chem. Soc. 78: 756. 